S
Sera Economics
← US Companies

NOVARTIS AG

NVS · NYSE, OTC · CIK 0001114448

SIC 2834

Pharmaceutical Preparations

Category

Chemicals

Entity

other

Incorp.

V8

Fiscal Y/E

1231

Source: SEC EDGAR · All filings on SEC →

Investment Indicators

$145.19

-0.84 (-0.58%)

Open

$146.59

High

$147.28

Low

$144.73

Prev Close

$146.03

Volume

2,004,661

Quote as of: 2026-05-11

Financial Statements

No XBRL data — applies to ETFs and some funds

📄 SEC Filings

Other filings (71)
144

144

xsl144X01/primary_doc.xml

2026-04-30

Open →

424B5

424B5

424B5

2026-03-17

Open →

FWP

FWP

FWP

2026-03-17

Open →

424B5

424B5

424B5

2026-03-16

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-12

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-09

Open →

S-8

S-8

FORM S-8

2026-02-04

Open →

IRANNOTICE

IRANNOTICE

a260204IRAN.htm

2026-02-04

Open →

S-8 POS

S-8 POS

S-8 POS

2026-01-16

Open →

S-8 POS

S-8 POS

S-8 POS

2026-01-16

Open →

S-8 POS

S-8 POS

S-8 POS

2026-01-16

Open →

S-8 POS

S-8 POS

S-8 POS

2026-01-16

Open →

DFAN14A

DFAN14A

DFAN14A

2026-01-14

Open →

DFAN14A

DFAN14A

DFAN14A

2026-01-12

Open →

424B5

424B5

424B5

2025-11-04

Open →

FWP

FWP

FWP

2025-11-04

Open →

424B5

424B5

424B5

2025-11-03

Open →

DFAN14A

DFAN14A

DFAN14A

2025-10-28

Open →

3

3

OWNERSHIP DOCUMENT

2025-10-28

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2025-10-28

Open →

DFAN14A

DFAN14A

DFAN14A

2025-10-28

Open →

DFAN14A

DFAN14A

DFAN14A

2025-10-27

Open →

DFAN14A

DFAN14A

DFAN14A

2025-10-27

Open →

DFAN14A

DFAN14A

DFAN14A

2025-10-27

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2025-10-22

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2025-10-20

Open →

SC TO-T

SC TO-T

SC TO-T

2025-09-29

Open →

SC TO-C

SC TO-C

SC TO-C

2025-09-09

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X01/primary_doc.xml

2025-07-17

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2025-06-25

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2025-06-23

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2025-06-17

Open →

SC TO-T

SC TO-T

SC TO-T

2025-05-27

Open →

144

144

xsl144X01/primary_doc.xml

2025-05-23

Open →

SC TO-C

SC TO-C

SC TO-C

2025-05-01

Open →

SC TO-C

SC TO-C

SC TO-C

2025-04-30

Open →

144

144

xsl144X01/primary_doc.xml

2025-04-30

Open →

UPLOAD

UPLOAD

filename1.pdf

2025-04-08

Open →

CORRESP

CORRESP

filename1.htm

2025-03-31

Open →

UPLOAD

UPLOAD

filename1.pdf

2025-03-18

Open →

IRANNOTICE

IRANNOTICE

IRANNOTICE

2025-01-31

Open →

SC 13D/A

SC 13D/A

SC 13D/A

2024-10-17

Open →

424B5

424B5

424B5

2024-09-17

Open →

FWP

FWP

FWP

2024-09-16

Open →

424B5

424B5

424B5

2024-09-16

Open →

F-3ASR

F-3ASR

F-3ASR

2024-09-16

Open →

SC 13D/A

SC 13D/A

SC 13D/A

2024-08-15

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-08-13

Open →

144

144

xsl144X01/primary_doc.xml

2024-08-12

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-08-07

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-08-02

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-08-01

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-07-31

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-07-30

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-07-29

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-07-25

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-07-18

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-07-11

Open →

SC TO-T

SC TO-T

SC TO-T

2024-07-05

Open →

SC 13D/A

SC 13D/A

SC 13D/A

2024-06-21

Open →

SC TO-C

SC TO-C

SC TO-C

2024-06-20

Open →

SC 13D/A

SC 13D/A

SC 13D/A

2024-06-17

Open →

SC 13D/A

SC 13D/A

SC 13D/A

2024-06-10

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-06-04

Open →

SD

SD

FORM SD

2024-05-31

Open →

SC 13D/A

SC 13D/A

SC 13D/A

2024-05-28

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-05-24

Open →

144

144

xsl144X01/primary_doc.xml

2024-05-22

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-05-16

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-05-13

Open →

SC TO-T/A

SC TO-T/A

SC TO-T/A

2024-05-10

Open →

NOVARTIS AG (NVS) — Pharmaceutical Preparations | Sera Economics